Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) — Net Asset Quality Index
Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has a Net Asset Quality Index of 38.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs553.64 Million minus total liabilities of Rs340.59 Million yields net assets of Rs213.04 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Biofil Chemicals & Pharmaceuticals Limit to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biofil Chemicals & Pharmaceuticals Limited Net Asset Quality Index Over Time (2008–2025)
This chart shows how Biofil Chemicals & Pharmaceuticals Limited's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of September 2025, the index stands at 38.5%, representing net assets of Rs213.04 Million against total assets of Rs553.64 Million INR. See Biofil Chemicals & Pharmaceuticals Limit short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BIOFILCHEM company net worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 36.9% | Rs187.82 Million | Rs509.60 Million | Rs321.79 Million | ▼ -1.8 pp |
| 2024 | 38.7% | Rs182.03 Million | Rs470.83 Million | Rs288.80 Million | ▼ -16.4 pp |
| 2023 | 55.1% | Rs173.01 Million | Rs314.06 Million | Rs141.04 Million | ▼ -34.8 pp |
| 2022 | 89.9% | Rs168.38 Million | Rs187.32 Million | Rs18.95 Million | ▲ +41.4 pp |
| 2021 | 48.5% | Rs161.29 Million | Rs332.38 Million | Rs171.09 Million | ▲ +13.4 pp |
| 2020 | 35.1% | Rs148.83 Million | Rs423.65 Million | Rs274.82 Million | ▼ -21.2 pp |
| 2019 | 56.4% | Rs136.50 Million | Rs242.13 Million | Rs105.63 Million | ▲ +1.9 pp |
| 2018 | 54.5% | Rs131.67 Million | Rs241.55 Million | Rs109.87 Million | ▼ -3.6 pp |
| 2017 | 58.1% | Rs126.96 Million | Rs218.40 Million | Rs91.44 Million | ▲ +12.9 pp |
| 2016 | 45.2% | Rs109.07 Million | Rs241.32 Million | Rs132.25 Million | ▼ -16.0 pp |
| 2015 | 61.2% | Rs84.15 Million | Rs137.56 Million | Rs53.42 Million | ▲ +7.3 pp |
| 2014 | 53.9% | Rs78.63 Million | Rs145.99 Million | Rs67.36 Million | ▼ -0.7 pp |
| 2013 | 54.6% | Rs73.62 Million | Rs134.93 Million | Rs61.31 Million | ▲ +6.1 pp |
| 2012 | 48.5% | Rs68.36 Million | Rs141.09 Million | Rs72.73 Million | ▼ -16.1 pp |
| 2011 | 64.6% | Rs67.02 Million | Rs103.81 Million | Rs36.79 Million | ▲ +47.7 pp |
| 2010 | 16.8% | Rs17.27 Million | Rs102.52 Million | Rs85.25 Million | ▲ +2.6 pp |
| 2009 | 14.3% | Rs11.99 Million | Rs83.97 Million | Rs71.99 Million | ▼ -1.5 pp |
| 2008 | 15.8% | Rs14.78 Million | Rs93.79 Million | Rs79.01 Million | — |